My latest conceptual project with Northhighland/Sparksgrove showing the parallels between Financial markets and Big Pharma over the digital age.

1. CUSTOMERS BENEFIT FROM INDUSTRY SHIFTS
How the Financial Services and Pharmaceutical industries are innovating and evolving
INSTITUTION INSTITUTION INSTITUTION
EMPOWERMENT
Greater access to relevant data
ADVISOR/DOCTOR CLIENT/PATIENT
TECHNOLOGY DATA CONTEXT SENSE & RESPOND
Financial
Pharma Services
PROFESSIONAL CONTROLLED
“Brokered” access
dilutes trust and value
INFORMED CONSUMER
"Selected” access, yet
poorly connected channels
CONSUMER DIRECTED
“Full” access, delivered
seamlessly across multiple
data-enabled channels
SHIFT OF TRUST
More reliance on social proof
REGULATIONS DATA
CLIENT/PATIENT ADVISOR/DOCTOR
REGULATIONS DATA
REGULATIONS
DATA
ADVISOR/
DOCTOR
EXPERIENCE ENABLEMENT TIMELINE
Probable
Possible
Plausible
Pharma
Predictive
diagnostics
HIT enabled
treatment plans
Real-time
health monitoring
Personalized
medicine
Financial Services
Crowd-sourced
identity
Distributed
currency systems
Open APIs
Open source
hardware & apps
CLIENT/
PATIENT